Calgary, Alberta – Wednesday, February 18, 2026 – Marvel Biosciences Corp. (TSXV: MRVL | OTC: MBCOF), is pleased to announce that it is receiving advisory services and funding from the National Research Council of Canada Industrial Research Assistance Program (NRC...
